期刊文献+

慢性粒细胞白血病急非淋变与急淋变的临床对比分析 被引量:3

原文传递
导出
摘要 目的 探讨慢性粒细胞白血病 (CML)急非淋变与急淋变治疗前的特点及其对治疗反应的差异。方法 对我院 6 1例CML急非淋变与急淋变患者治疗前临床及实验室检查特点及其对治疗的反应进行回顾性对比分析。结果 CML急变时 ,急非淋变与急淋变相比 ,急非淋变发生率高 ,发病年龄偏大 ,肝大、巨脾的发生率高 ,贫血较重 ,外周血白细胞总数较多 ,幼稚细胞比例高 ,骨髓幼稚细胞比例低 ,血清乳酸脱氢酶水平高 ,CD34+ 和CD34+ /HLA -DR+ 表达率高 ,附加染色体的发生率高 ,治疗反应差。结论 急非淋变与急淋变相比 ,具有不同的临床特征、实验室特点及不同的治疗反应 ,这对临床分型具有重要的意义。
出处 《中国综合临床》 北大核心 2004年第4期305-307,共3页 Clinical Medicine of China
  • 相关文献

参考文献15

  • 1Yen CC, Liu JH, Wang WS, et al. Immunophenotypic and genotypic characteristics of chronic myelogenous leukemia in blast crisis[ J].Zhonghua Yi Xue Za Zhi(Tai pei) ,2000,63(11) :785-791.
  • 2Yamaguchi H, Inokuchi K, Sakuma Y, et al. Mutation of the P 51/P 63 gene is associated with blastic crisis in chronic myelogenoua leukemia[ J]. Leukemia,2001,15 ( 11 ): 1729-1734.
  • 3Gaiger A, Henn T, C eissler K, et al. Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression[ J]. Blood, 1995,15:86(6):2371-2378.
  • 4Fenaux P. The clinical significance of mutation of the P53 tumor auppresser gene in hematological malignancies[ J]. Br J Haematol,1997,98(1) :502-511.
  • 5Carapeti M, Soede B A, Hochhaus A, et al. Rarity of dominant-negative mutations of the G-CSF receptor in patients with blast crisis of chronic myeloid leukemia or de novo acute leukemia[ J]. Leukemia,1997,11 (2) :1005-1008.
  • 6Handa H, Hegde UP, Kotelnikov VW, et al. Bcl-2 and c-myc exqression,cell cycle kinetics and apoptosis during the progression of cbronic myeloid leukemia from diagnosis to blast crisis [ J ]. Leu Res,1997,21 ( 1 ) :479-489.
  • 7Derderian PM,Kantarjian HM,Talpaz M,et al. Chronic myelogenous leukemia in the lymphoid blastic phase:characteristic,treatment response,and prognosis[ J]. Am J Med,1993 ,94(1) :69-74.
  • 8Bradstock K, Matthews J, Benson E, et al. Prognostic value of immunophenotyping in acute myeloid leukemia[ J]. Blood, 1994 ,84(4):1220-1225.
  • 9Kosui N,Tojo A,Shinaki H, et al. The preferential expression of CD7 and CD34 in nyeloid blast crisis in chronic myeloid leukemia[J]. Blood,2000,95 (6) :2188-2189.
  • 10Ver:faillie CM,Bhatia R,Miller W,et al. Bcr/abl-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early chronic phase but not accelerated-phase chronic myelogenous leukemia patients [ J]. Blood, 1996, 87 (

共引文献64

同被引文献32

  • 1宋建新,苏敏,张芹,方蒡,甸自金,欧阳红梅,陈斌,台虹.282例急性白血病流式细胞术免疫分型的特点分析[J].现代检验医学杂志,2005,20(1):35-38. 被引量:11
  • 2张之南,沈悌,主编.血液病诊断与疗效标准[M].北京:科学出版社,2007,220.
  • 3Wadhwa J,Szydlo R M,Apperley J F,et al.Factors affecting duration of survival after onset of blastic transformation of chronic myeloid leukemia[J].Blood,2002,99:2304-2309.
  • 4Khalidi H,Brynes R,Medeiros L,et al.The immunophenotype of blast transformation of chronic myelogenous leukemia:a high frequency of mixed lineage phenotype in "lymphoid" blasts and a comparison of morphologic,immunophenotypic,and molecular findings[J].Mod Pathol,1998,11:1211-1221.
  • 5Favre G,Passweg J,Hoffmann T,et al.Immunophenotype of blast crisis in chronic myeloid leukemia[J].Schweiz Med Wochenschr,1998,128:1624-1626.
  • 6Lopez-Karpovitch X,Cardenas R,Piedras J.Immunophenotypic characteristics of the blast crisis in chronic myeloid leukemia[J].Rev Invest Clin,1997,49:31-36.
  • 7Banavali S,Silvestri F,Hulette B,et al.Expression of hematopoietic progenitor cell associated antigen CD34 in chronic myeloid leukemia[J].Leuk Res,1991,15:603-608.
  • 8Normann AP,Egeland T,Madshus I H,et al.CD7 expression by CD34+ cells in CML patients,of prognostic significance?[J].Eur J Haematol,2003,71:266-275.
  • 9Kosugi N,Ebihara Y,Nakahata T,et al.CD34+CD7+ leukemic progenitor cells may be involved in maintenance and clonal evolution of chronic myeloid leukemia[J].Clin Cancer Res,2005,11:505-511.
  • 10Ball E,Davis R,Griffin J,et al.Prognostic value of lymphocyte surface markers in acute myeloid leukemia[J].Blood,1991,77:2242-2250.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部